| Summary Data |
Vs.
Industry |
Vs.
Board |
Vs.
KLSE |
| Balance Sheet |
|
|
|
| Current Assets |
5/6 |
1/1 |
19/23 |
| Long-term Assets |
5/6 |
1/1 |
18/23 |
| Total Assets |
5/6 |
1/1 |
14/23 |
| Current Liabilities |
6/6 |
1/1 |
22/23 |
| Long-term Liabilities |
5/6 |
1/1 |
18/23 |
| Stockholder's Equity |
5/6 |
1/1 |
19/23 |
| Total Liabilities |
6/6 |
1/1 |
16/23 |
Total Stockholder's Equity
and Liabilities |
5/6 |
1/1 |
14/23 |
| Income Statement |
|
|
|
| Revenues |
6/6 |
1/1 |
22/23 |
| Operating Income |
6/6 |
1/1 |
21/23 |
| EBITDA |
6/6 |
1/1 |
21/23 |
| Net Income |
6/6 |
1/1 |
21/23 |
| Statement of Cash Flows |
|
|
|
| Operating Activities |
6/6 |
1/1 |
20/23 |
| Investing Activities |
3/6 |
1/1 |
11/23 |
| Financing Activities |
4/6 |
1/1 |
13/23 |
| Total |
6/6 |
1/1 |
21/23 |
| Beginning of Period |
1/6 |
1/1 |
2/23 |
| Effects of Exchange Rate Changes |
2/6 |
1/1 |
4/23 |
| End of Period |
3/6 |
1/1 |
8/23 |
| Statement of Stockholder's Equity |
|
|
|
| Shares Outstanding |
5/6 |
1/1 |
19/23 |
| Current Price |
5/6 |
1/1 |
21/23 |
| Market Capitalization |
5/6 |
1/1 |
19/23 |
| 52 Week High |
5/6 |
1/1 |
20/23 |
| 52 Week Low |
5/6 |
1/1 |
20/23 |
| Retained Earnings |
6/6 |
1/1 |
20/23 |
| Key Metrics |
Vs.
Industry |
Vs.
Board |
Vs.
KLSE |
| Performance |
|
|
|
| Net Operating Margin |
4/6 |
1/1 |
18/23 |
| Net Income Margin |
6/6 |
1/1 |
22/23 |
| Return on Equity |
6/6 |
1/1 |
22/23 |
| Financing/Liquidity |
|
|
|
| Working Capital |
5/6 |
1/1 |
15/23 |
| Current Ratio |
1/6 |
1/1 |
1/23 |
| Debt/Total Assets |
6/6 |
1/1 |
17/23 |
| Debt/Equity |
6/6 |
1/1 |
17/23 |
| Valuation |
|
|
|
| P/E |
5/6 |
1/1 |
19/23 |
| Market Cap/Revenues |
2/6 |
1/1 |
6/23 |
| Other Ratios |
|
|
|
| Return on Assets (ROA) |
6/6 |
1/1 |
22/23 |
| Return on Common Equity (ROCE) |
6/6 |
1/1 |
22/23 |
| Earnings Per Share (EPS) |
6/6 |
1/1 |
21/23 |
| Market to Book Ratio |
3/6 |
1/1 |
16/23 |
